Aethlon Medical Announces Stock Symbol Change to ``AEMD''.

Business Editors & Health/Medical Writers

SAN DIEGO--(BW HealthWire)--April 4, 2000

Aethlon Medical, Inc. (OTCBB:BSEQ), (OTCBB:AEMD) today announced that effective April 4, 2000, its securities will trade under the new symbol "AEMD".

Previously, the company's securities traded under the symbol "BSEQ." Shareholders are advised to make a note of this stock symbol change.

In related news, the company filed an amendment of its certificate of incorporation with the Nevada Secretary of State, officially adopting the corporate name "Aethlon Medical, Inc." effective as of March 28, 2000. Prior to this change, the company had operated as Bishop Equities, Inc. dba Aethlon Medical, Inc. The number of shares voting in favor of the amendment exceeded the percentage vote requirement of more than 50 percent.

About Aethlon Medical

Aethlon Medical is a leading developer of extracorporeal treatment technologies. Utilizing a proprietary platform technology known as the Hemopurifier(TM), Aethlon Medical is able to remove targeted intoxicants from the blood without the side effects normally associated with other methods of treatment.

The first family of Hemopurifiers to be commercialized have been developed for the purpose of removing harmful metal intoxicants, including iron, lead, and cisplatin. Other products now in development include Hemopurifiers that treat plutonium intoxication, drug overdoses, and Hemopurifiers designed to reduce the body burden of viruses such as HIV and Hepatitis C.

For more information on recent developments at the company, visit the Aethlon Medical Web site at http://www.aethlonmedical.com

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. (the "Company"), or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

Readers of this press release may obtain additional information on the company in reports and other information filed in accordance with the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Such reports and other information filed by the company can be inspected and copied at the public reference facilities maintained by the Commission at the Public Reference Room, 450 Fifth Street, N.W., Washington, DC 20549.

Copies of such material can also be obtained at prescribed rates from the Public Reference Section of the Commission, Washington, DC 20549 or by calling the Commission at 800/SEC-0330.

In addition, Registration Statements and other filings made with the Commission through its Electronic Data Gathering Analysis and Retrieval System ("EDGAR") are publicly available through the Commission's Web site located at http://www.sec.gov.